INS and metabolic syndrome: The hormonal changes can trigger a cascade of events that lead to tissue resistance to insulin, ultimately contributing to the development of metabolic syndrome, cardiovascular diseases, proinflammatory alterations, and prothrombotic changes, resulting in increased morbidity [75,76].